Our Products

Letrozole Tablets USP 2.5 mg is a medication primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is an aromatase inhibitor that works by inhibiting the aromatase enzyme, which is responsible for the conversion of androgens into estrogen. By lowering estrogen levels, Letrozole helps slow or stop the growth of breast cancer cells that depend on estrogen for their growth.

The 2.5 mg dosage is typically taken once daily, as prescribed by a healthcare provider. Common side effects include hot flashes, joint pain, fatigue, and an increased risk of osteoporosis. Regular monitoring, including bone density tests, is recommended during treatment. Letrozole is also used as an adjuvant therapy following surgery to help reduce the risk of cancer recurrence.